Are Wall Street Analysts Bullish on AbbVie Stock?

With a market cap of $356.2 billion, North Chicago, Illinois-based AbbVie Inc. (ABBV) operates in the pharmaceutical sector. Known for its innovative therapies, the company offers a diverse portfolio covering immunology, oncology, neuroscience, aesthetics, and eye care, positioning it as a global leader in healthcare solutions.

The drugmaker's shares have outperformed the broader market over the past 52 weeks. ABBV has surged 42.5% over this time frame, while the broader S&P 500 Index ($SPX) has increased 35.8%. In 2024, shares of ABBV are up 29.8%, compared to SPX’s 24.3% rise on a YTD basis.